Exome Asset Management LLC Buys 7,027 Shares of UnitedHealth Group Incorporated $UNH

Exome Asset Management LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 120.4% during the first quarter, HoldingsChannel.com reports. The fund owned 12,862 shares of the healthcare conglomerate’s stock after purchasing an additional 7,027 shares during the quarter. UnitedHealth Group comprises approximately 1.8% of Exome Asset Management LLC’s holdings, making the stock its 17th biggest position. Exome Asset Management LLC’s holdings in UnitedHealth Group were worth $3,480,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the company. Vaughan David Investments LLC IL boosted its position in shares of UnitedHealth Group by 2.7% during the 4th quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate’s stock valued at $49,772,000 after acquiring an additional 3,934 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. raised its stake in UnitedHealth Group by 1,287.2% during the first quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock valued at $16,241,000 after purchasing an additional 55,695 shares in the last quarter. J. Safra Sarasin Holding AG grew its stake in shares of UnitedHealth Group by 127.6% in the 4th quarter. J. Safra Sarasin Holding AG now owns 34,947 shares of the healthcare conglomerate’s stock worth $11,536,000 after buying an additional 19,591 shares in the last quarter. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock valued at $30,238,162,000 after buying an additional 995,210 shares in the last quarter. Finally, Sumitomo Mitsui Financial Group Inc. grew its position in UnitedHealth Group by 8.7% in the fourth quarter. Sumitomo Mitsui Financial Group Inc. now owns 102,260 shares of the healthcare conglomerate’s stock worth $33,757,000 after acquiring an additional 8,226 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

UNH stock opened at $416.89 on Tuesday. The firm has a market cap of $378.59 billion, a price-to-earnings ratio of 26.83, a PEG ratio of 1.46 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $461.62. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The business’s fifty day simple moving average is $408.53 and its two-hundred day simple moving average is $346.11.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the prior year, the business posted $4.08 earnings per share. The business’s revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were issued a $2.32 dividend. The ex-dividend date was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on UNH. Barclays raised their price objective on UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research note on Monday, July 20th. KeyCorp increased their price target on UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and boosted their price objective for the company from $287.00 to $453.00 in a research report on Thursday, July 16th. Piper Sandler set a $477.00 target price on shares of UnitedHealth Group in a report on Thursday, July 16th. Finally, Erste Group Bank raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $455.92.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.